drugset / Trial / NCT06062550

Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery

NCT06062550

Phase 4 Active not recruiting 312 enrolled Peking University First Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Scoliosis correction surgery is associated with severe pain. Patients after scoliosis correction surgery usually require high dose opioids and long duration analgesia, which may increase side effects and drug tolerance. In a recent trial, mini-dose esketamine and dexmedetomidine combination as a supplement to sufentanil significantly improved analgesia and subjective sleep quality after spinal correction surgery without increasing adverse events; however, the proportion of patients with moderate-to-severe pain remained high. The authors speculate that increasing esketamine dose in the combination may further improve analgesic effects.

Timeline

Start
2023-10-24
Primary completion
2025-10-23
Completion
2026-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 50 mg Intravenous
Subject Esketamine Other / unclassified 100 mg Intravenous
Subject Esketamine Other / unclassified 150 mg Intravenous